nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—Parkinson's disease—Rivastigmine—Alzheimer's disease	0.149	0.5	CpDpCtD
Amantadine—Parkinson's disease—Memantine—Alzheimer's disease	0.149	0.5	CpDpCtD
Amantadine—GRIN2B—Alzheimer's disease	0.125	0.561	CbGaD
Amantadine—MAOB—Alzheimer's disease	0.098	0.439	CbGaD
Amantadine—GRIN1—Memantine—Alzheimer's disease	0.0758	0.233	CbGbCtD
Amantadine—GRIN2B—Memantine—Alzheimer's disease	0.069	0.212	CbGbCtD
Amantadine—GRIN2A—Memantine—Alzheimer's disease	0.069	0.212	CbGbCtD
Amantadine—GRIN3A—Memantine—Alzheimer's disease	0.0458	0.141	CbGbCtD
Amantadine—SIGMAR1—Donepezil—Alzheimer's disease	0.0376	0.115	CbGbCtD
Amantadine—SLC22A2—Memantine—Alzheimer's disease	0.017	0.052	CbGbCtD
Amantadine—DRD2—Memantine—Alzheimer's disease	0.0118	0.0361	CbGbCtD
Amantadine—GRIN1—telencephalic ventricle—Alzheimer's disease	0.00254	0.0841	CbGeAlD
Amantadine—GRIN2B—telencephalic ventricle—Alzheimer's disease	0.00242	0.0802	CbGeAlD
Amantadine—DDC—telencephalic ventricle—Alzheimer's disease	0.00198	0.0655	CbGeAlD
Amantadine—DRD2—telencephalic ventricle—Alzheimer's disease	0.000859	0.0284	CbGeAlD
Amantadine—GRIN2C—forebrain—Alzheimer's disease	0.000801	0.0265	CbGeAlD
Amantadine—GRIN2D—forebrain—Alzheimer's disease	0.000744	0.0246	CbGeAlD
Amantadine—GRIN2C—telencephalon—Alzheimer's disease	0.000736	0.0244	CbGeAlD
Amantadine—GRIN3A—forebrain—Alzheimer's disease	0.0007	0.0232	CbGeAlD
Amantadine—GRIN2D—telencephalon—Alzheimer's disease	0.000684	0.0226	CbGeAlD
Amantadine—GRIN1—forebrain—Alzheimer's disease	0.000663	0.0219	CbGeAlD
Amantadine—GRIN3A—telencephalon—Alzheimer's disease	0.000643	0.0213	CbGeAlD
Amantadine—GRIN2B—forebrain—Alzheimer's disease	0.000633	0.0209	CbGeAlD
Amantadine—GRIN1—telencephalon—Alzheimer's disease	0.00061	0.0202	CbGeAlD
Amantadine—DDC—embryo—Alzheimer's disease	0.000584	0.0193	CbGeAlD
Amantadine—GRIN2B—telencephalon—Alzheimer's disease	0.000582	0.0193	CbGeAlD
Amantadine—GRIN2A—forebrain—Alzheimer's disease	0.000553	0.0183	CbGeAlD
Amantadine—DDC—forebrain—Alzheimer's disease	0.000517	0.0171	CbGeAlD
Amantadine—GRIN2A—telencephalon—Alzheimer's disease	0.000509	0.0168	CbGeAlD
Amantadine—DDC—telencephalon—Alzheimer's disease	0.000475	0.0157	CbGeAlD
Amantadine—GRIN2C—nervous system—Alzheimer's disease	0.000435	0.0144	CbGeAlD
Amantadine—GRIN2C—central nervous system—Alzheimer's disease	0.000418	0.0138	CbGeAlD
Amantadine—GRIN2C—cerebellum—Alzheimer's disease	0.000409	0.0135	CbGeAlD
Amantadine—GRIN2D—nervous system—Alzheimer's disease	0.000404	0.0134	CbGeAlD
Amantadine—GRIN2D—central nervous system—Alzheimer's disease	0.000389	0.0129	CbGeAlD
Amantadine—GRIN2D—cerebellum—Alzheimer's disease	0.00038	0.0126	CbGeAlD
Amantadine—GRIN3A—nervous system—Alzheimer's disease	0.00038	0.0126	CbGeAlD
Amantadine—GRIN3A—central nervous system—Alzheimer's disease	0.000366	0.0121	CbGeAlD
Amantadine—GRIN1—nervous system—Alzheimer's disease	0.00036	0.0119	CbGeAlD
Amantadine—GRIN1—central nervous system—Alzheimer's disease	0.000347	0.0115	CbGeAlD
Amantadine—GRIN2B—nervous system—Alzheimer's disease	0.000344	0.0114	CbGeAlD
Amantadine—GRIN1—cerebellum—Alzheimer's disease	0.000339	0.0112	CbGeAlD
Amantadine—GRIN2C—brain—Alzheimer's disease	0.000332	0.011	CbGeAlD
Amantadine—GRIN2B—central nervous system—Alzheimer's disease	0.000331	0.0109	CbGeAlD
Amantadine—GRIN2B—cerebellum—Alzheimer's disease	0.000323	0.0107	CbGeAlD
Amantadine—GRIN2D—brain—Alzheimer's disease	0.000309	0.0102	CbGeAlD
Amantadine—SLC22A1—forebrain—Alzheimer's disease	0.000301	0.00995	CbGeAlD
Amantadine—MAOB—embryo—Alzheimer's disease	0.000301	0.00995	CbGeAlD
Amantadine—GRIN2A—nervous system—Alzheimer's disease	0.0003	0.00994	CbGeAlD
Amantadine—GRIN3A—brain—Alzheimer's disease	0.00029	0.00961	CbGeAlD
Amantadine—GRIN2A—central nervous system—Alzheimer's disease	0.000289	0.00957	CbGeAlD
Amantadine—GRIN2A—cerebellum—Alzheimer's disease	0.000283	0.00935	CbGeAlD
Amantadine—DDC—nervous system—Alzheimer's disease	0.000281	0.00928	CbGeAlD
Amantadine—SLC22A1—telencephalon—Alzheimer's disease	0.000276	0.00915	CbGeAlD
Amantadine—GRIN1—brain—Alzheimer's disease	0.000275	0.00911	CbGeAlD
Amantadine—DDC—central nervous system—Alzheimer's disease	0.00027	0.00894	CbGeAlD
Amantadine—MAOB—forebrain—Alzheimer's disease	0.000266	0.0088	CbGeAlD
Amantadine—GRIN2B—brain—Alzheimer's disease	0.000263	0.00869	CbGeAlD
Amantadine—SIGMAR1—telencephalon—Alzheimer's disease	0.000255	0.00845	CbGeAlD
Amantadine—MAOB—telencephalon—Alzheimer's disease	0.000244	0.00809	CbGeAlD
Amantadine—GRIN2A—brain—Alzheimer's disease	0.00023	0.00759	CbGeAlD
Amantadine—Hypertonia—Rivastigmine—Alzheimer's disease	0.000226	0.00348	CcSEcCtD
Amantadine—Hyperkinesia—Rivastigmine—Alzheimer's disease	0.000225	0.00346	CcSEcCtD
Amantadine—DRD2—forebrain—Alzheimer's disease	0.000224	0.00742	CbGeAlD
Amantadine—Mental disability—Rivastigmine—Alzheimer's disease	0.000224	0.00344	CcSEcCtD
Amantadine—Cardiac failure—Donepezil—Alzheimer's disease	0.000216	0.00332	CcSEcCtD
Amantadine—DDC—brain—Alzheimer's disease	0.000214	0.0071	CbGeAlD
Amantadine—Disorientation—Memantine—Alzheimer's disease	0.000214	0.00329	CcSEcCtD
Amantadine—Eczema—Memantine—Alzheimer's disease	0.000213	0.00327	CcSEcCtD
Amantadine—Cardiac failure congestive—Memantine—Alzheimer's disease	0.000211	0.00324	CcSEcCtD
Amantadine—Osteoarthritis—Donepezil—Alzheimer's disease	0.000211	0.00324	CcSEcCtD
Amantadine—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.000209	0.00321	CcSEcCtD
Amantadine—Eczema—Rivastigmine—Alzheimer's disease	0.000209	0.0032	CcSEcCtD
Amantadine—Renal failure acute—Memantine—Alzheimer's disease	0.000208	0.00319	CcSEcCtD
Amantadine—Libido decreased—Memantine—Alzheimer's disease	0.000207	0.00317	CcSEcCtD
Amantadine—DRD2—telencephalon—Alzheimer's disease	0.000206	0.00683	CbGeAlD
Amantadine—Psychotic disorder—Donepezil—Alzheimer's disease	0.000206	0.00316	CcSEcCtD
Amantadine—Amnesia—Memantine—Alzheimer's disease	0.000204	0.00313	CcSEcCtD
Amantadine—Renal failure acute—Rivastigmine—Alzheimer's disease	0.000203	0.00312	CcSEcCtD
Amantadine—Libido decreased—Rivastigmine—Alzheimer's disease	0.000202	0.0031	CcSEcCtD
Amantadine—Irritability—Donepezil—Alzheimer's disease	0.000201	0.00309	CcSEcCtD
Amantadine—Urinary retention—Donepezil—Alzheimer's disease	0.000201	0.00308	CcSEcCtD
Amantadine—Amnesia—Rivastigmine—Alzheimer's disease	0.0002	0.00306	CcSEcCtD
Amantadine—Ataxia—Donepezil—Alzheimer's disease	0.000198	0.00305	CcSEcCtD
Amantadine—Cardiac failure—Memantine—Alzheimer's disease	0.000196	0.00301	CcSEcCtD
Amantadine—Lethargy—Memantine—Alzheimer's disease	0.000196	0.003	CcSEcCtD
Amantadine—Liver function test abnormal—Donepezil—Alzheimer's disease	0.000195	0.00299	CcSEcCtD
Amantadine—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000193	0.00296	CcSEcCtD
Amantadine—Cardiac failure—Rivastigmine—Alzheimer's disease	0.000192	0.00295	CcSEcCtD
Amantadine—Osteoarthritis—Memantine—Alzheimer's disease	0.000192	0.00294	CcSEcCtD
Amantadine—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.00019	0.00292	CcSEcCtD
Amantadine—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.000187	0.00288	CcSEcCtD
Amantadine—Hallucination—Galantamine—Alzheimer's disease	0.000187	0.00288	CcSEcCtD
Amantadine—Psychotic disorder—Memantine—Alzheimer's disease	0.000187	0.00287	CcSEcCtD
Amantadine—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000186	0.00286	CcSEcCtD
Amantadine—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.000186	0.00286	CcSEcCtD
Amantadine—Oedema peripheral—Galantamine—Alzheimer's disease	0.000186	0.00285	CcSEcCtD
Amantadine—Urethral disorder—Galantamine—Alzheimer's disease	0.000185	0.00284	CcSEcCtD
Amantadine—ABCB1—blood vessel—Alzheimer's disease	0.000184	0.00608	CbGeAlD
Amantadine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000183	0.00281	CcSEcCtD
Amantadine—Irritability—Memantine—Alzheimer's disease	0.000183	0.00281	CcSEcCtD
Amantadine—Dysphagia—Donepezil—Alzheimer's disease	0.000182	0.0028	CcSEcCtD
Amantadine—Cardiac arrest—Memantine—Alzheimer's disease	0.000182	0.0028	CcSEcCtD
Amantadine—Urinary retention—Memantine—Alzheimer's disease	0.000182	0.0028	CcSEcCtD
Amantadine—Visual impairment—Galantamine—Alzheimer's disease	0.000182	0.00279	CcSEcCtD
Amantadine—Ataxia—Memantine—Alzheimer's disease	0.00018	0.00277	CcSEcCtD
Amantadine—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.000178	0.00274	CcSEcCtD
Amantadine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000178	0.00274	CcSEcCtD
Amantadine—Sweating increased—Donepezil—Alzheimer's disease	0.000178	0.00273	CcSEcCtD
Amantadine—Liver function test abnormal—Memantine—Alzheimer's disease	0.000177	0.00272	CcSEcCtD
Amantadine—Ataxia—Rivastigmine—Alzheimer's disease	0.000176	0.00271	CcSEcCtD
Amantadine—Eye disorder—Galantamine—Alzheimer's disease	0.000176	0.0027	CcSEcCtD
Amantadine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000175	0.00269	CcSEcCtD
Amantadine—Cardiac disorder—Galantamine—Alzheimer's disease	0.000175	0.00268	CcSEcCtD
Amantadine—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000173	0.00266	CcSEcCtD
Amantadine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000171	0.00263	CcSEcCtD
Amantadine—Angiopathy—Galantamine—Alzheimer's disease	0.000171	0.00262	CcSEcCtD
Amantadine—Arrhythmia—Galantamine—Alzheimer's disease	0.000168	0.00258	CcSEcCtD
Amantadine—Dysphagia—Memantine—Alzheimer's disease	0.000166	0.00254	CcSEcCtD
Amantadine—Mental disorder—Galantamine—Alzheimer's disease	0.000165	0.00253	CcSEcCtD
Amantadine—Malnutrition—Galantamine—Alzheimer's disease	0.000164	0.00252	CcSEcCtD
Amantadine—SLC22A1—nervous system—Alzheimer's disease	0.000163	0.0054	CbGeAlD
Amantadine—Dysphagia—Rivastigmine—Alzheimer's disease	0.000162	0.00249	CcSEcCtD
Amantadine—Sweating increased—Memantine—Alzheimer's disease	0.000161	0.00248	CcSEcCtD
Amantadine—Tension—Galantamine—Alzheimer's disease	0.000161	0.00247	CcSEcCtD
Amantadine—Nervousness—Galantamine—Alzheimer's disease	0.000159	0.00245	CcSEcCtD
Amantadine—Sweating increased—Rivastigmine—Alzheimer's disease	0.000158	0.00242	CcSEcCtD
Amantadine—SLC22A1—central nervous system—Alzheimer's disease	0.000157	0.0052	CbGeAlD
Amantadine—Neutropenia—Memantine—Alzheimer's disease	0.000155	0.00238	CcSEcCtD
Amantadine—Vision blurred—Galantamine—Alzheimer's disease	0.000155	0.00237	CcSEcCtD
Amantadine—Tremor—Galantamine—Alzheimer's disease	0.000154	0.00236	CcSEcCtD
Amantadine—Agitation—Galantamine—Alzheimer's disease	0.000151	0.00231	CcSEcCtD
Amantadine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000148	0.00227	CcSEcCtD
Amantadine—Hallucination—Donepezil—Alzheimer's disease	0.000145	0.00223	CcSEcCtD
Amantadine—Palpitations—Galantamine—Alzheimer's disease	0.000145	0.00222	CcSEcCtD
Amantadine—MAOB—nervous system—Alzheimer's disease	0.000144	0.00478	CbGeAlD
Amantadine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000144	0.00221	CcSEcCtD
Amantadine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000144	0.00221	CcSEcCtD
Amantadine—Urethral disorder—Donepezil—Alzheimer's disease	0.000143	0.0022	CcSEcCtD
Amantadine—Convulsion—Galantamine—Alzheimer's disease	0.000142	0.00218	CcSEcCtD
Amantadine—SIGMAR1—cerebellum—Alzheimer's disease	0.000142	0.00469	CbGeAlD
Amantadine—Hypertension—Galantamine—Alzheimer's disease	0.000142	0.00217	CcSEcCtD
Amantadine—Visual impairment—Donepezil—Alzheimer's disease	0.000141	0.00216	CcSEcCtD
Amantadine—Anxiety—Galantamine—Alzheimer's disease	0.000139	0.00214	CcSEcCtD
Amantadine—MAOB—central nervous system—Alzheimer's disease	0.000139	0.0046	CbGeAlD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000139	0.00213	CcSEcCtD
Amantadine—Agranulocytosis—Memantine—Alzheimer's disease	0.000138	0.00212	CcSEcCtD
Amantadine—Dry mouth—Galantamine—Alzheimer's disease	0.000137	0.0021	CcSEcCtD
Amantadine—MAOB—cerebellum—Alzheimer's disease	0.000136	0.00449	CbGeAlD
Amantadine—Confusional state—Galantamine—Alzheimer's disease	0.000135	0.00207	CcSEcCtD
Amantadine—Hallucination—Memantine—Alzheimer's disease	0.000132	0.00202	CcSEcCtD
Amantadine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000131	0.00202	CcSEcCtD
Amantadine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000131	0.00201	CcSEcCtD
Amantadine—Tachycardia—Galantamine—Alzheimer's disease	0.000131	0.00201	CcSEcCtD
Amantadine—Oedema peripheral—Memantine—Alzheimer's disease	0.000131	0.002	CcSEcCtD
Amantadine—Arrhythmia—Donepezil—Alzheimer's disease	0.00013	0.002	CcSEcCtD
Amantadine—Skin disorder—Galantamine—Alzheimer's disease	0.00013	0.002	CcSEcCtD
Amantadine—Urethral disorder—Memantine—Alzheimer's disease	0.00013	0.00199	CcSEcCtD
Amantadine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000129	0.00199	CcSEcCtD
Amantadine—Hallucination—Rivastigmine—Alzheimer's disease	0.000129	0.00198	CcSEcCtD
Amantadine—Alopecia—Donepezil—Alzheimer's disease	0.000129	0.00198	CcSEcCtD
Amantadine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000128	0.00197	CcSEcCtD
Amantadine—Mental disorder—Donepezil—Alzheimer's disease	0.000128	0.00196	CcSEcCtD
Amantadine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000128	0.00196	CcSEcCtD
Amantadine—Visual impairment—Memantine—Alzheimer's disease	0.000128	0.00196	CcSEcCtD
Amantadine—Anorexia—Galantamine—Alzheimer's disease	0.000128	0.00196	CcSEcCtD
Amantadine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000127	0.00195	CcSEcCtD
Amantadine—Malnutrition—Donepezil—Alzheimer's disease	0.000127	0.00195	CcSEcCtD
Amantadine—Hypotension—Galantamine—Alzheimer's disease	0.000125	0.00192	CcSEcCtD
Amantadine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000125	0.00192	CcSEcCtD
Amantadine—SLC22A1—brain—Alzheimer's disease	0.000125	0.00413	CbGeAlD
Amantadine—Tension—Donepezil—Alzheimer's disease	0.000125	0.00191	CcSEcCtD
Amantadine—Eye disorder—Memantine—Alzheimer's disease	0.000124	0.0019	CcSEcCtD
Amantadine—Nervousness—Donepezil—Alzheimer's disease	0.000123	0.0019	CcSEcCtD
Amantadine—Cardiac disorder—Memantine—Alzheimer's disease	0.000123	0.00189	CcSEcCtD
Amantadine—DRD2—nervous system—Alzheimer's disease	0.000122	0.00403	CbGeAlD
Amantadine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000121	0.00186	CcSEcCtD
Amantadine—Insomnia—Galantamine—Alzheimer's disease	0.000121	0.00186	CcSEcCtD
Amantadine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00012	0.00185	CcSEcCtD
Amantadine—Angiopathy—Memantine—Alzheimer's disease	0.00012	0.00185	CcSEcCtD
Amantadine—Paraesthesia—Galantamine—Alzheimer's disease	0.00012	0.00185	CcSEcCtD
Amantadine—Vision blurred—Donepezil—Alzheimer's disease	0.00012	0.00184	CcSEcCtD
Amantadine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000119	0.00183	CcSEcCtD
Amantadine—Tremor—Donepezil—Alzheimer's disease	0.000119	0.00183	CcSEcCtD
Amantadine—Somnolence—Galantamine—Alzheimer's disease	0.000119	0.00183	CcSEcCtD
Amantadine—Arrhythmia—Memantine—Alzheimer's disease	0.000118	0.00182	CcSEcCtD
Amantadine—Dyspepsia—Galantamine—Alzheimer's disease	0.000118	0.00181	CcSEcCtD
Amantadine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000118	0.00181	CcSEcCtD
Amantadine—DRD2—central nervous system—Alzheimer's disease	0.000117	0.00388	CbGeAlD
Amantadine—Alopecia—Memantine—Alzheimer's disease	0.000117	0.0018	CcSEcCtD
Amantadine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000117	0.00179	CcSEcCtD
Amantadine—Agitation—Donepezil—Alzheimer's disease	0.000117	0.00179	CcSEcCtD
Amantadine—Decreased appetite—Galantamine—Alzheimer's disease	0.000116	0.00179	CcSEcCtD
Amantadine—Mental disorder—Memantine—Alzheimer's disease	0.000116	0.00178	CcSEcCtD
Amantadine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000116	0.00178	CcSEcCtD
Amantadine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000116	0.00177	CcSEcCtD
Amantadine—Malnutrition—Memantine—Alzheimer's disease	0.000115	0.00177	CcSEcCtD
Amantadine—Fatigue—Galantamine—Alzheimer's disease	0.000115	0.00177	CcSEcCtD
Amantadine—SIGMAR1—brain—Alzheimer's disease	0.000115	0.00381	CbGeAlD
Amantadine—DRD2—cerebellum—Alzheimer's disease	0.000115	0.00379	CbGeAlD
Amantadine—Alopecia—Rivastigmine—Alzheimer's disease	0.000115	0.00176	CcSEcCtD
Amantadine—Constipation—Galantamine—Alzheimer's disease	0.000114	0.00176	CcSEcCtD
Amantadine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000114	0.00174	CcSEcCtD
Amantadine—Tension—Memantine—Alzheimer's disease	0.000113	0.00174	CcSEcCtD
Amantadine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000113	0.00173	CcSEcCtD
Amantadine—Nervousness—Memantine—Alzheimer's disease	0.000112	0.00172	CcSEcCtD
Amantadine—Tension—Rivastigmine—Alzheimer's disease	0.000111	0.0017	CcSEcCtD
Amantadine—MAOB—brain—Alzheimer's disease	0.00011	0.00365	CbGeAlD
Amantadine—Feeling abnormal—Galantamine—Alzheimer's disease	0.00011	0.00169	CcSEcCtD
Amantadine—Convulsion—Donepezil—Alzheimer's disease	0.00011	0.00169	CcSEcCtD
Amantadine—Hypertension—Donepezil—Alzheimer's disease	0.00011	0.00168	CcSEcCtD
Amantadine—ABCB1—embryo—Alzheimer's disease	0.00011	0.00363	CbGeAlD
Amantadine—Nervousness—Rivastigmine—Alzheimer's disease	0.00011	0.00168	CcSEcCtD
Amantadine—Vision blurred—Memantine—Alzheimer's disease	0.000109	0.00167	CcSEcCtD
Amantadine—Tremor—Memantine—Alzheimer's disease	0.000108	0.00166	CcSEcCtD
Amantadine—Anxiety—Donepezil—Alzheimer's disease	0.000108	0.00166	CcSEcCtD
Amantadine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000106	0.00163	CcSEcCtD
Amantadine—Agitation—Memantine—Alzheimer's disease	0.000106	0.00163	CcSEcCtD
Amantadine—Dry mouth—Donepezil—Alzheimer's disease	0.000106	0.00162	CcSEcCtD
Amantadine—Body temperature increased—Galantamine—Alzheimer's disease	0.000106	0.00162	CcSEcCtD
Amantadine—Tremor—Rivastigmine—Alzheimer's disease	0.000106	0.00162	CcSEcCtD
Amantadine—Confusional state—Donepezil—Alzheimer's disease	0.000105	0.00161	CcSEcCtD
Amantadine—Agitation—Rivastigmine—Alzheimer's disease	0.000104	0.00159	CcSEcCtD
Amantadine—Oedema—Donepezil—Alzheimer's disease	0.000104	0.00159	CcSEcCtD
Amantadine—Leukopenia—Memantine—Alzheimer's disease	0.000103	0.00159	CcSEcCtD
Amantadine—Palpitations—Memantine—Alzheimer's disease	0.000102	0.00157	CcSEcCtD
Amantadine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000102	0.00156	CcSEcCtD
Amantadine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.0001	0.00154	CcSEcCtD
Amantadine—Convulsion—Memantine—Alzheimer's disease	0.0001	0.00153	CcSEcCtD
Amantadine—Palpitations—Rivastigmine—Alzheimer's disease	9.98e-05	0.00153	CcSEcCtD
Amantadine—Hypertension—Memantine—Alzheimer's disease	9.96e-05	0.00153	CcSEcCtD
Amantadine—Anorexia—Donepezil—Alzheimer's disease	9.89e-05	0.00152	CcSEcCtD
Amantadine—Hypersensitivity—Galantamine—Alzheimer's disease	9.86e-05	0.00151	CcSEcCtD
Amantadine—Anxiety—Memantine—Alzheimer's disease	9.79e-05	0.0015	CcSEcCtD
Amantadine—Convulsion—Rivastigmine—Alzheimer's disease	9.78e-05	0.0015	CcSEcCtD
Amantadine—Hypertension—Rivastigmine—Alzheimer's disease	9.75e-05	0.0015	CcSEcCtD
Amantadine—ABCB1—forebrain—Alzheimer's disease	9.7e-05	0.00321	CbGeAlD
Amantadine—Hypotension—Donepezil—Alzheimer's disease	9.69e-05	0.00149	CcSEcCtD
Amantadine—Dry mouth—Memantine—Alzheimer's disease	9.61e-05	0.00148	CcSEcCtD
Amantadine—Asthenia—Galantamine—Alzheimer's disease	9.6e-05	0.00147	CcSEcCtD
Amantadine—Anxiety—Rivastigmine—Alzheimer's disease	9.58e-05	0.00147	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	9.54e-05	0.00147	CcSEcCtD
Amantadine—Confusional state—Memantine—Alzheimer's disease	9.5e-05	0.00146	CcSEcCtD
Amantadine—Oedema—Memantine—Alzheimer's disease	9.42e-05	0.00145	CcSEcCtD
Amantadine—Dry mouth—Rivastigmine—Alzheimer's disease	9.4e-05	0.00144	CcSEcCtD
Amantadine—Insomnia—Donepezil—Alzheimer's disease	9.38e-05	0.00144	CcSEcCtD
Amantadine—Paraesthesia—Donepezil—Alzheimer's disease	9.31e-05	0.00143	CcSEcCtD
Amantadine—DRD2—brain—Alzheimer's disease	9.31e-05	0.00308	CbGeAlD
Amantadine—Confusional state—Rivastigmine—Alzheimer's disease	9.29e-05	0.00143	CcSEcCtD
Amantadine—Dyspnoea—Donepezil—Alzheimer's disease	9.25e-05	0.00142	CcSEcCtD
Amantadine—Nervous system disorder—Memantine—Alzheimer's disease	9.24e-05	0.00142	CcSEcCtD
Amantadine—Somnolence—Donepezil—Alzheimer's disease	9.22e-05	0.00142	CcSEcCtD
Amantadine—Oedema—Rivastigmine—Alzheimer's disease	9.21e-05	0.00141	CcSEcCtD
Amantadine—Tachycardia—Memantine—Alzheimer's disease	9.19e-05	0.00141	CcSEcCtD
Amantadine—Diarrhoea—Galantamine—Alzheimer's disease	9.16e-05	0.00141	CcSEcCtD
Amantadine—Skin disorder—Memantine—Alzheimer's disease	9.15e-05	0.0014	CcSEcCtD
Amantadine—Dyspepsia—Donepezil—Alzheimer's disease	9.13e-05	0.0014	CcSEcCtD
Amantadine—Hyperhidrosis—Memantine—Alzheimer's disease	9.1e-05	0.0014	CcSEcCtD
Amantadine—Nervous system disorder—Rivastigmine—Alzheimer's disease	9.03e-05	0.00139	CcSEcCtD
Amantadine—Decreased appetite—Donepezil—Alzheimer's disease	9.02e-05	0.00138	CcSEcCtD
Amantadine—Tachycardia—Rivastigmine—Alzheimer's disease	8.99e-05	0.00138	CcSEcCtD
Amantadine—Anorexia—Memantine—Alzheimer's disease	8.98e-05	0.00138	CcSEcCtD
Amantadine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	8.95e-05	0.00137	CcSEcCtD
Amantadine—Skin disorder—Rivastigmine—Alzheimer's disease	8.95e-05	0.00137	CcSEcCtD
Amantadine—Fatigue—Donepezil—Alzheimer's disease	8.94e-05	0.00137	CcSEcCtD
Amantadine—ABCB1—telencephalon—Alzheimer's disease	8.92e-05	0.00295	CbGeAlD
Amantadine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	8.91e-05	0.00137	CcSEcCtD
Amantadine—Constipation—Donepezil—Alzheimer's disease	8.87e-05	0.00136	CcSEcCtD
Amantadine—Dizziness—Galantamine—Alzheimer's disease	8.85e-05	0.00136	CcSEcCtD
Amantadine—Hypotension—Memantine—Alzheimer's disease	8.8e-05	0.00135	CcSEcCtD
Amantadine—Anorexia—Rivastigmine—Alzheimer's disease	8.78e-05	0.00135	CcSEcCtD
Amantadine—Hypotension—Rivastigmine—Alzheimer's disease	8.61e-05	0.00132	CcSEcCtD
Amantadine—Feeling abnormal—Donepezil—Alzheimer's disease	8.55e-05	0.00131	CcSEcCtD
Amantadine—Insomnia—Memantine—Alzheimer's disease	8.52e-05	0.00131	CcSEcCtD
Amantadine—Vomiting—Galantamine—Alzheimer's disease	8.51e-05	0.00131	CcSEcCtD
Amantadine—Paraesthesia—Memantine—Alzheimer's disease	8.46e-05	0.0013	CcSEcCtD
Amantadine—Rash—Galantamine—Alzheimer's disease	8.44e-05	0.0013	CcSEcCtD
Amantadine—Dermatitis—Galantamine—Alzheimer's disease	8.43e-05	0.00129	CcSEcCtD
Amantadine—Dyspnoea—Memantine—Alzheimer's disease	8.4e-05	0.00129	CcSEcCtD
Amantadine—Headache—Galantamine—Alzheimer's disease	8.38e-05	0.00129	CcSEcCtD
Amantadine—Somnolence—Memantine—Alzheimer's disease	8.37e-05	0.00129	CcSEcCtD
Amantadine—Insomnia—Rivastigmine—Alzheimer's disease	8.33e-05	0.00128	CcSEcCtD
Amantadine—Dyspepsia—Memantine—Alzheimer's disease	8.29e-05	0.00127	CcSEcCtD
Amantadine—Paraesthesia—Rivastigmine—Alzheimer's disease	8.27e-05	0.00127	CcSEcCtD
Amantadine—Dyspnoea—Rivastigmine—Alzheimer's disease	8.21e-05	0.00126	CcSEcCtD
Amantadine—Body temperature increased—Donepezil—Alzheimer's disease	8.2e-05	0.00126	CcSEcCtD
Amantadine—Somnolence—Rivastigmine—Alzheimer's disease	8.19e-05	0.00126	CcSEcCtD
Amantadine—Decreased appetite—Memantine—Alzheimer's disease	8.19e-05	0.00126	CcSEcCtD
Amantadine—Gastrointestinal disorder—Memantine—Alzheimer's disease	8.13e-05	0.00125	CcSEcCtD
Amantadine—Fatigue—Memantine—Alzheimer's disease	8.12e-05	0.00125	CcSEcCtD
Amantadine—Dyspepsia—Rivastigmine—Alzheimer's disease	8.11e-05	0.00125	CcSEcCtD
Amantadine—Constipation—Memantine—Alzheimer's disease	8.05e-05	0.00124	CcSEcCtD
Amantadine—Decreased appetite—Rivastigmine—Alzheimer's disease	8.01e-05	0.00123	CcSEcCtD
Amantadine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	7.95e-05	0.00122	CcSEcCtD
Amantadine—Nausea—Galantamine—Alzheimer's disease	7.95e-05	0.00122	CcSEcCtD
Amantadine—Fatigue—Rivastigmine—Alzheimer's disease	7.94e-05	0.00122	CcSEcCtD
Amantadine—Constipation—Rivastigmine—Alzheimer's disease	7.88e-05	0.00121	CcSEcCtD
Amantadine—Feeling abnormal—Memantine—Alzheimer's disease	7.76e-05	0.00119	CcSEcCtD
Amantadine—Hypersensitivity—Donepezil—Alzheimer's disease	7.64e-05	0.00117	CcSEcCtD
Amantadine—Feeling abnormal—Rivastigmine—Alzheimer's disease	7.59e-05	0.00117	CcSEcCtD
Amantadine—Body temperature increased—Memantine—Alzheimer's disease	7.44e-05	0.00114	CcSEcCtD
Amantadine—Asthenia—Donepezil—Alzheimer's disease	7.44e-05	0.00114	CcSEcCtD
Amantadine—Pruritus—Donepezil—Alzheimer's disease	7.34e-05	0.00113	CcSEcCtD
Amantadine—Body temperature increased—Rivastigmine—Alzheimer's disease	7.28e-05	0.00112	CcSEcCtD
Amantadine—Diarrhoea—Donepezil—Alzheimer's disease	7.1e-05	0.00109	CcSEcCtD
Amantadine—Hypersensitivity—Memantine—Alzheimer's disease	6.94e-05	0.00107	CcSEcCtD
Amantadine—Dizziness—Donepezil—Alzheimer's disease	6.86e-05	0.00105	CcSEcCtD
Amantadine—Hypersensitivity—Rivastigmine—Alzheimer's disease	6.79e-05	0.00104	CcSEcCtD
Amantadine—Asthenia—Memantine—Alzheimer's disease	6.76e-05	0.00104	CcSEcCtD
Amantadine—Pruritus—Memantine—Alzheimer's disease	6.66e-05	0.00102	CcSEcCtD
Amantadine—Asthenia—Rivastigmine—Alzheimer's disease	6.61e-05	0.00101	CcSEcCtD
Amantadine—Vomiting—Donepezil—Alzheimer's disease	6.59e-05	0.00101	CcSEcCtD
Amantadine—Rash—Donepezil—Alzheimer's disease	6.54e-05	0.001	CcSEcCtD
Amantadine—Dermatitis—Donepezil—Alzheimer's disease	6.53e-05	0.001	CcSEcCtD
Amantadine—Pruritus—Rivastigmine—Alzheimer's disease	6.52e-05	0.001	CcSEcCtD
Amantadine—Headache—Donepezil—Alzheimer's disease	6.5e-05	0.000998	CcSEcCtD
Amantadine—Diarrhoea—Memantine—Alzheimer's disease	6.44e-05	0.000989	CcSEcCtD
Amantadine—Diarrhoea—Rivastigmine—Alzheimer's disease	6.3e-05	0.000968	CcSEcCtD
Amantadine—Dizziness—Memantine—Alzheimer's disease	6.23e-05	0.000956	CcSEcCtD
Amantadine—Nausea—Donepezil—Alzheimer's disease	6.16e-05	0.000946	CcSEcCtD
Amantadine—Dizziness—Rivastigmine—Alzheimer's disease	6.09e-05	0.000935	CcSEcCtD
Amantadine—Vomiting—Memantine—Alzheimer's disease	5.99e-05	0.000919	CcSEcCtD
Amantadine—Rash—Memantine—Alzheimer's disease	5.94e-05	0.000912	CcSEcCtD
Amantadine—Dermatitis—Memantine—Alzheimer's disease	5.93e-05	0.000911	CcSEcCtD
Amantadine—Headache—Memantine—Alzheimer's disease	5.9e-05	0.000906	CcSEcCtD
Amantadine—Vomiting—Rivastigmine—Alzheimer's disease	5.86e-05	0.000899	CcSEcCtD
Amantadine—Rash—Rivastigmine—Alzheimer's disease	5.81e-05	0.000892	CcSEcCtD
Amantadine—Dermatitis—Rivastigmine—Alzheimer's disease	5.8e-05	0.000891	CcSEcCtD
Amantadine—Headache—Rivastigmine—Alzheimer's disease	5.77e-05	0.000886	CcSEcCtD
Amantadine—Nausea—Memantine—Alzheimer's disease	5.59e-05	0.000859	CcSEcCtD
Amantadine—Nausea—Rivastigmine—Alzheimer's disease	5.47e-05	0.00084	CcSEcCtD
Amantadine—ABCB1—nervous system—Alzheimer's disease	5.26e-05	0.00174	CbGeAlD
Amantadine—ABCB1—central nervous system—Alzheimer's disease	5.07e-05	0.00168	CbGeAlD
Amantadine—ABCB1—cerebellum—Alzheimer's disease	4.95e-05	0.00164	CbGeAlD
Amantadine—ABCB1—brain—Alzheimer's disease	4.02e-05	0.00133	CbGeAlD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	5.55e-06	9.51e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PLCB1—Alzheimer's disease	5.54e-06	9.5e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	5.49e-06	9.41e-05	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	5.43e-06	9.3e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GAL—Alzheimer's disease	5.4e-06	9.26e-05	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—CREB1—Alzheimer's disease	5.38e-06	9.23e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—ABCA1—Alzheimer's disease	5.37e-06	9.21e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS1—Alzheimer's disease	5.32e-06	9.12e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ENO1—Alzheimer's disease	5.32e-06	9.12e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYP2D6—Alzheimer's disease	5.22e-06	8.94e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—DHCR24—Alzheimer's disease	5.11e-06	8.76e-05	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	5.07e-06	8.69e-05	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—CREB1—Alzheimer's disease	5.02e-06	8.6e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—BCHE—Alzheimer's disease	4.94e-06	8.47e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GAL—Alzheimer's disease	4.91e-06	8.41e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TTR—Alzheimer's disease	4.78e-06	8.2e-05	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	4.76e-06	8.16e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PLCB1—Alzheimer's disease	4.67e-06	8e-05	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	4.65e-06	7.98e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PPARGC1A—Alzheimer's disease	4.63e-06	7.94e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—HMOX1—Alzheimer's disease	4.61e-06	7.9e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ABCA1—Alzheimer's disease	4.52e-06	7.75e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	4.43e-06	7.59e-05	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	4.4e-06	7.53e-05	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	4.35e-06	7.45e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CA4—Alzheimer's disease	4.34e-06	7.45e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—NPY—Alzheimer's disease	4.24e-06	7.28e-05	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	4.24e-06	7.27e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CCR5—Alzheimer's disease	4.22e-06	7.24e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—IAPP—Alzheimer's disease	4.22e-06	7.23e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—LPL—Alzheimer's disease	4.22e-06	7.23e-05	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—MAPK8—Alzheimer's disease	4.2e-06	7.21e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PYY—Alzheimer's disease	4.18e-06	7.17e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR2A—Alzheimer's disease	4.13e-06	7.08e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—VEGFA—Alzheimer's disease	4.12e-06	7.06e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	4.1e-06	7.02e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CRH—Alzheimer's disease	4.1e-06	7.02e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	4.09e-06	7e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	4.04e-06	6.92e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—VEGFA—Alzheimer's disease	4.02e-06	6.88e-05	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—IL6—Alzheimer's disease	3.99e-06	6.84e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	3.98e-06	6.83e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PPARGC1A—Alzheimer's disease	3.9e-06	6.68e-05	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—IL6—Alzheimer's disease	3.89e-06	6.67e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TPI1—Alzheimer's disease	3.88e-06	6.66e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CHAT—Alzheimer's disease	3.88e-06	6.66e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—NPS—Alzheimer's disease	3.88e-06	6.65e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—HMOX1—Alzheimer's disease	3.88e-06	6.65e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	3.87e-06	6.64e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—NPY—Alzheimer's disease	3.85e-06	6.61e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	3.83e-06	6.57e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IAPP—Alzheimer's disease	3.83e-06	6.57e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—MTHFR—Alzheimer's disease	3.8e-06	6.51e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TGFB1—Alzheimer's disease	3.78e-06	6.48e-05	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	3.74e-06	6.4e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MAOB—Alzheimer's disease	3.72e-06	6.38e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CRH—Alzheimer's disease	3.72e-06	6.37e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—SST—Alzheimer's disease	3.7e-06	6.35e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GAB2—Alzheimer's disease	3.7e-06	6.35e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLD3—Alzheimer's disease	3.69e-06	6.33e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TGFB1—Alzheimer's disease	3.69e-06	6.32e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CDK5—Alzheimer's disease	3.63e-06	6.22e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—F2—Alzheimer's disease	3.62e-06	6.21e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TPI1—Alzheimer's disease	3.62e-06	6.21e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CHAT—Alzheimer's disease	3.62e-06	6.21e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—APP—Alzheimer's disease	3.61e-06	6.19e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GAPDH—Alzheimer's disease	3.58e-06	6.14e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—LPL—Alzheimer's disease	3.55e-06	6.08e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—CALM1—Alzheimer's disease	3.55e-06	6.08e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	3.54e-06	6.07e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—APOE—Alzheimer's disease	3.53e-06	6.06e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TNF—Alzheimer's disease	3.53e-06	6.05e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—NPS—Alzheimer's disease	3.53e-06	6.04e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PPP3CA—Alzheimer's disease	3.51e-06	6.01e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—CAV1—Alzheimer's disease	3.5e-06	6e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR6—Alzheimer's disease	3.49e-06	5.98e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MAOB—Alzheimer's disease	3.47e-06	5.95e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—A2M—Alzheimer's disease	3.46e-06	5.93e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TNF—Alzheimer's disease	3.44e-06	5.9e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	3.43e-06	5.89e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	3.41e-06	5.84e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PLCB1—Alzheimer's disease	3.41e-06	5.84e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—SST—Alzheimer's disease	3.36e-06	5.76e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GAB2—Alzheimer's disease	3.36e-06	5.76e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	3.34e-06	5.73e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GAPDH—Alzheimer's disease	3.34e-06	5.73e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ND1—Alzheimer's disease	3.29e-06	5.64e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—APP—Alzheimer's disease	3.28e-06	5.62e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CCL2—Alzheimer's disease	3.23e-06	5.54e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—A2M—Alzheimer's disease	3.23e-06	5.53e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MTHFR—Alzheimer's disease	3.19e-06	5.48e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	3.18e-06	5.45e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PSENEN—Alzheimer's disease	3.17e-06	5.43e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APH1A—Alzheimer's disease	3.13e-06	5.36e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PLCB1—Alzheimer's disease	3.09e-06	5.3e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PPARG—Alzheimer's disease	3.08e-06	5.28e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NCSTN—Alzheimer's disease	3.04e-06	5.22e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—INS—Alzheimer's disease	3.02e-06	5.17e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ACHE—Alzheimer's disease	3.01e-06	5.16e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CALM1—Alzheimer's disease	2.98e-06	5.12e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—INPP5D—Alzheimer's disease	2.98e-06	5.1e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—APOE—Alzheimer's disease	2.97e-06	5.1e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LRP1—Alzheimer's disease	2.97e-06	5.09e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.95e-06	5.06e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CAV1—Alzheimer's disease	2.95e-06	5.05e-05	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—Alzheimer's disease	2.93e-06	5.03e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GAL—Alzheimer's disease	2.9e-06	4.97e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GFAP—Alzheimer's disease	2.9e-06	4.97e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—IL6—Alzheimer's disease	2.85e-06	4.88e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS1—Alzheimer's disease	2.82e-06	4.84e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ENO1—Alzheimer's disease	2.82e-06	4.84e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ACHE—Alzheimer's disease	2.81e-06	4.81e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—IL6—Alzheimer's disease	2.78e-06	4.76e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—INPP5D—Alzheimer's disease	2.77e-06	4.76e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP2D6—Alzheimer's disease	2.77e-06	4.74e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.71e-06	4.65e-05	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—IL6—Alzheimer's disease	2.68e-06	4.6e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—NOS3—Alzheimer's disease	2.65e-06	4.54e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ENO1—Alzheimer's disease	2.63e-06	4.51e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS1—Alzheimer's disease	2.63e-06	4.51e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—AKT1—Alzheimer's disease	2.63e-06	4.51e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—BCHE—Alzheimer's disease	2.62e-06	4.5e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PPARG—Alzheimer's disease	2.59e-06	4.44e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP2D6—Alzheimer's disease	2.58e-06	4.42e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—AKT1—Alzheimer's disease	2.56e-06	4.39e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—A2M—Alzheimer's disease	2.55e-06	4.38e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—INS—Alzheimer's disease	2.54e-06	4.36e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.52e-06	4.32e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.5e-06	4.29e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PLCB1—Alzheimer's disease	2.48e-06	4.24e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PSEN2—Alzheimer's disease	2.47e-06	4.24e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—BCHE—Alzheimer's disease	2.45e-06	4.19e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTGS2—Alzheimer's disease	2.42e-06	4.15e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.4e-06	4.12e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ABCA1—Alzheimer's disease	2.4e-06	4.11e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CCR5—Alzheimer's disease	2.39e-06	4.09e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.34e-06	4e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PLCB1—Alzheimer's disease	2.31e-06	3.96e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.3e-06	3.94e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PRKCG—Alzheimer's disease	2.29e-06	3.92e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NPY—Alzheimer's disease	2.28e-06	3.9e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IAPP—Alzheimer's disease	2.26e-06	3.88e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ABCA1—Alzheimer's disease	2.24e-06	3.83e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—NOS3—Alzheimer's disease	2.23e-06	3.82e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CRH—Alzheimer's disease	2.2e-06	3.77e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCR5—Alzheimer's disease	2.17e-06	3.71e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.14e-06	3.68e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TPI1—Alzheimer's disease	2.12e-06	3.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CHAT—Alzheimer's disease	2.12e-06	3.64e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2A—Alzheimer's disease	2.12e-06	3.64e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NPS—Alzheimer's disease	2.08e-06	3.57e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PPP3CA—Alzheimer's disease	2.07e-06	3.55e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARGC1A—Alzheimer's disease	2.07e-06	3.55e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—HMOX1—Alzheimer's disease	2.06e-06	3.53e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—F2—Alzheimer's disease	2.05e-06	3.51e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTK2B—Alzheimer's disease	2.04e-06	3.5e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS2—Alzheimer's disease	2.04e-06	3.49e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MAOB—Alzheimer's disease	2.03e-06	3.49e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GAB2—Alzheimer's disease	1.99e-06	3.41e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NTRK2—Alzheimer's disease	1.99e-06	3.41e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SST—Alzheimer's disease	1.99e-06	3.41e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CALM1—Alzheimer's disease	1.98e-06	3.39e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GSK3A—Alzheimer's disease	1.97e-06	3.38e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.96e-06	3.36e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APP—Alzheimer's disease	1.94e-06	3.32e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARGC1A—Alzheimer's disease	1.93e-06	3.3e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HMOX1—Alzheimer's disease	1.92e-06	3.29e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—A2M—Alzheimer's disease	1.89e-06	3.24e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.89e-06	3.24e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—LPL—Alzheimer's disease	1.88e-06	3.23e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—F2—Alzheimer's disease	1.86e-06	3.19e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PLCB1—Alzheimer's disease	1.83e-06	3.13e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—LPL—Alzheimer's disease	1.76e-06	3.01e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NGFR—Alzheimer's disease	1.7e-06	2.92e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MTHFR—Alzheimer's disease	1.7e-06	2.91e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CREB1—Alzheimer's disease	1.69e-06	2.9e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADAM10—Alzheimer's disease	1.66e-06	2.85e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCL2—Alzheimer's disease	1.66e-06	2.84e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.65e-06	2.82e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.63e-06	2.79e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.6e-06	2.74e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CALM1—Alzheimer's disease	1.58e-06	2.71e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MTHFR—Alzheimer's disease	1.58e-06	2.71e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOE—Alzheimer's disease	1.58e-06	2.71e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—S100B—Alzheimer's disease	1.57e-06	2.7e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CAV1—Alzheimer's disease	1.56e-06	2.68e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.54e-06	2.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.54e-06	2.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.51e-06	2.59e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	1.5e-06	2.57e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CALM1—Alzheimer's disease	1.48e-06	2.53e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOE—Alzheimer's disease	1.47e-06	2.52e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CAV1—Alzheimer's disease	1.46e-06	2.5e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	1.45e-06	2.48e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.43e-06	2.46e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LPL—Alzheimer's disease	1.39e-06	2.38e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	1.38e-06	2.36e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARG—Alzheimer's disease	1.37e-06	2.36e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	1.35e-06	2.32e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	1.35e-06	2.32e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—INS—Alzheimer's disease	1.35e-06	2.31e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NGF—Alzheimer's disease	1.32e-06	2.26e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.31e-06	2.25e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARG—Alzheimer's disease	1.28e-06	2.2e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	1.28e-06	2.19e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—INS—Alzheimer's disease	1.26e-06	2.15e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	1.25e-06	2.15e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—AKT1—Alzheimer's disease	1.22e-06	2.09e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NOS3—Alzheimer's disease	1.18e-06	2.03e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	1.17e-06	2e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LEP—Alzheimer's disease	1.16e-06	2e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOE—Alzheimer's disease	1.16e-06	2e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	1.15e-06	1.98e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.13e-06	1.94e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.12e-06	1.93e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	1.11e-06	1.91e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NOS3—Alzheimer's disease	1.1e-06	1.89e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—F2—Alzheimer's disease	1.1e-06	1.88e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS2—Alzheimer's disease	1.08e-06	1.85e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.07e-06	1.84e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LPL—Alzheimer's disease	1.03e-06	1.76e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AKT1—Alzheimer's disease	1.02e-06	1.76e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	1.01e-06	1.73e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS2—Alzheimer's disease	1.01e-06	1.73e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	1e-06	1.72e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—INS—Alzheimer's disease	9.95e-07	1.71e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	9.79e-07	1.68e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	9.62e-07	1.65e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	9.26e-07	1.59e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	8.73e-07	1.5e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CALM1—Alzheimer's disease	8.65e-07	1.48e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOE—Alzheimer's disease	8.62e-07	1.48e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CAV1—Alzheimer's disease	8.54e-07	1.46e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARG—Alzheimer's disease	7.51e-07	1.29e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	7.48e-07	1.28e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	7.41e-07	1.27e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—INS—Alzheimer's disease	7.37e-07	1.26e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	7.36e-07	1.26e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	6.81e-07	1.17e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	6.79e-07	1.16e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NOS3—Alzheimer's disease	6.46e-07	1.11e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	6.29e-07	1.08e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	5.91e-07	1.01e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	5.77e-07	9.89e-06	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AKT1—Alzheimer's disease	5.44e-07	9.32e-06	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AKT1—Alzheimer's disease	5.07e-07	8.68e-06	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	4.75e-07	8.14e-06	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	4.35e-07	7.45e-06	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	4.01e-07	6.88e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKT1—Alzheimer's disease	2.97e-07	5.09e-06	CbGpPWpGaD
